基于人工智能的痴呆病因差异诊断基于多式联络数据的多式联络数据
Chonghua Xue1,2, Sahana S Kowshik1,3, Diala Lteif1,4
1Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Nature medicine
|July 4, 2024
概括
一个人工智能 (AI) 模型使用各种数据准确识别痴呆症的原因,改善诊断和管理. 这种人工智能工具可以提高神经病学家的表现,帮助早期诊断和为痴呆症患者提供个性化的护理策略.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 精确的痴呆症诊断是具有挑战性的,因为各种原因的症状重叠.
- 早期和个性化的管理策略对于有效的痴呆症护理至关重要.
- 区分痴呆症病因对于有针对性的治疗方法至关重要.
研究的目的:
- 开发和验证人工智能 (AI) 模型,用于识别痴呆症病因.
- 用多式联络数据提高痴呆症诊断的准确性和效率.
- 评估AI模型在分类痴呆类型和混合痴呆病例方面的表现.
主要方法:
- 这项研究使用了来自9个不同数据集的51,269名参与者的大型数据集.
- 一个人工智能模型整合了人口统计,病史,认知评估和神经成像数据.
- 模型性能使用接收器操作特征曲线 (AUROC) 下的面积来评估.
主要成果:
- 人工智能模型实现了微平均AUROC为0.94的认知状态 (正常,MCI,痴呆症) 的分类.
- 它在区分10种不同的痴呆病因方面显示出微平均AUROC为0.96.
- 该模型显示了混合痴呆症病例的熟练程度 (平均AUROC为0.78) 和神经科医生的性能增强了26.25%.
结论:
- 人工智能模型在识别痴呆症原因和分类认知障碍方面表现出很高的准确性.
- 它有可能在临床环境和药物试验中成为一种有价值的查工具.
- 建议进行进一步的前性研究,以确认其对患者护理和治疗结果的影响.
相关概念视频
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461


